Tuesday 28 May 2019

Reuters Health Report: Oklahoma, Johnson & Johnson face off in first opioid crisis trial

Reuters.com Newsletter

Oklahoma, Johnson & Johnson face off in first opioid crisis trial

Drugmaker Johnson & Johnson is set to face trial in a multibillion-dollar lawsuit by the state of Oklahoma aimed at pinning the blame for the opioid epidemic on its painkiller marketing.

Factbox: Oklahoma becomes first U.S. state to take drugmakers to trial over opioids

Johnson & Johnson is set to face trial on Tuesday in a multi-billion dollar lawsuit by the state of Oklahoma accusing the drugmaker of helping fuel the opioid epidemic.

Oklahoma takes on drugmakers J&J, Teva in landmark opioid trial

Gail Box vividly remembers the day in May 2011 when she first learned her 22-year-old son Austin, a University of Oklahoma linebacker, was abusing opioid painkillers: It was the day he died of an overdose.

WHO sees high risk as polio breaks out in Central African Republic

Two cases of polio have been reported in the Central African Republic, the World Health Organization said in a report on Tuesday, the latest setback for global efforts to eradicate the crippling disease.

WHO agrees watered-down resolution on transparency in drug costs

World Health Organization members agreed on Tuesday to push for clearer drug pricing but stepped back from proposals by activists to force pharmaceutical firms to disclose the cost of making medicines.

Japan court says forced sterilizations unconstitutional, refuses compensation: media

The forced sterilization of two women decades ago as teenagers was unconstitutional, a Japanese court said on Tuesday, but rejected their demands for compensation, in the first of about 20 such cases closely watched nationwide, media said.

Newron delays schizophrenia drug trial after FDA raises concerns

Swiss-listed drugmaker Newron must delay a trial of its prospective schizophrenia medicine evenamide after the U.S. Food and Drug Administration raised concerns about central nervous system (CNS) events that have emerged in rats and dogs.

British Columbia to be first Canadian province to switch patients to biosimilars

The Canadian province of British Columbia said on Monday that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to cheap near-copies called biosimilars, saving an estimated C$96.6 million ($71.9 million)over three years.

Lopez Obrador says will shop abroad if necessary to fix medicine shortages

Mexican President Andres Manuel Lopez Obrador vowed on Monday to alleviate a medicine shortage in public hospitals, pledging to shop abroad for essential drugs if necessary and blaming the situation on companies upset about his crackdown on overpricing.

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

Cirrhosis, cancer risks higher with fatty liver - especially in diabetics

(Reuters Health) - Fatty liver disease that's not related to alcohol use is linked with an increased risk of cirrhosis and liver cancer, especially in people with diabetes, according to a large study from Europe.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS